Immunology

Potential new approach to enhancing stem-cell transplants

A discovery by a three-member Albert Einstein College of Medicine research team may boost the effectiveness of stem-cell transplants, commonly used for patients with cancer, blood disorders, or autoimmune diseases caused ...

Oncology & Cancer

Advances in multiple myeloma treatment

March is Myeloma Awareness Month. Multiple myeloma is a blood cancer that most often occurs in people over age 45. It's the second-most common blood cancer and the most common blood cancer in Black people.

Medications

Researchers say chemo drug may prevent heart failure

A chemotherapy drug used to fight bone-marrow cancer has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.

page 1 from 7

Bone marrow failure occurs in individuals who produce an insufficient amount of red blood cells, white blood cells or platelets. Red blood cells determine how much oxygen needs to be distributed throughout the body’s tissue. White blood cells are constantly helping fight off germs and infections that enter the body. Bone marrow contains platelets, which clot then helps stop the blood flow when a wound occurs.

This text uses material from Wikipedia licensed under CC BY-SA